Release according to Article 40, Section 1 of the WpHG

What happened

The Dutch regulator AFM disclosed on October 27, 2026 a voting rights notification for QIAGEN N.V. from Barclays Plc, dated October 22, 2026, listing holdings that include contracts for difference which carry potential voting rights.

Confirmed

Global impact / market context

Barclays holds a mix of real and potential voting rights tied to QIAGEN shares, so this disclosure shows how much influence a large bank could hold, which matters to investors tracking ownership and voting power.

Analyst inference

Such voting rights announcements are routine regulatory filings under German law, but a large bank's mix of swaps and contracts for difference, which are derivative bets on shares, can draw attention to possible hedging flows.

Analyst inference

What to watch

1. Whether Barclays later reports changes to its disclosed holdings, including the contract for difference position that carries potential voting rights rather than real votes. Confirmed
2. Watch for any shareholder meeting agenda where these potential voting rights could become real votes on QIAGEN matters. Proposed
3. Monitor whether Barclays reduces these derivative positions, which could affect demand for QIAGEN shares and the bank's disclosed voting influence. Analyst inference

Evidence

• Original source link unavailable